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Cholesterol and triglycerides (TG) received from dietary fats are insoluble in plasma, and 
therefore these compounds must be packed to lipoproteins when transported by the blood-
stream. Apolipoproteins are a group of proteins that are bound to lipoprotein particles, serv-
ing as cofactors for enzymes or as ligands for cellular binding. Apolipoprotein B exists in two 
forms: ApoB48 secreted by the intestine and apoB100 synthesized in the liver.  
 
Epidemiological studies have shown that elevated postprandial (non-fasting) TG concentra-
tions are a significant risk for cardiovascular diseases (CVD). Previous studies have shown 
that apoB48 protein serves as a good marker for postprandial triglyceride-rich chylomicrons 
and VLDL particles. Traditionally apoB48 has been measured with SDS-PAGE (sodium do-
decyl sulphate polyacrylamide gel electrophoresis) method from lipoprotein fractions sepa-
rated first by ultracentrifugation (UCF). This SDS-PAGE methodology used to determine the 
contribution of intestinal triglyceride-rich lipoproteins to postprandial lipemia has been very 
time consuming. A much less time-consuming method, the ELISA (enzyme-linked immuno-
sorbent assay) method by which apoB48 protein can be determined directly from plasma 
samples became available about ten years ago. The aim of this thesis is to assess the com-
parability of these two methods used to measure apoB48. 
 
The data for this method comparison was obtained from two clinical studies called the Fruc-
tose study and the Gere study. These studies included all-together 199 participants who all 
went through an 8-hour fat tolerance test at least once. In all, data consisted of 995 apoB48 
measurements performed by both methods, SDS-PAGE and ELISA.  
 
Current data show that the correlation coefficient of measured apoB48 concentrations (mg/l) 
between the methods varied from R = 0.563, P<0.001 to R = 0.844, P<0.001 depending on 
the concentration of apoB48 in the samples. Data also show that plasma apoB48 concen-
trations measured by ELISA method are 76 - 85 % higher than the apoB48 concentrations 
measured by the SDS-PAGE method from lipoprotein fractions. There was a strong positive 
correlation observed between the two methods R = 0.765, P<0.001.  
 
This study confirmed the earlier findings made with a smaller amount of data. ApoB48 con-
centration measured with ELISA directly from plasma reflects well the apoB48 concentration 
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measured from the lipoprotein fractions with SDS-PAGE. In the future, the less time-con-
suming apoB48 ELISA measurement could easily be implemented in clinical laboratories 
and used as a biological marker of intestinal chylomicron and VLDL particle number when 
evaluating the risk of CVD especially in hyper triglyceridemic patients. 
 
All the laboratory work and clinical studies were carried out at Biomedicum Helsinki, Re-
search Program Unit, Marja-Riitta Taskinen’s study group, Diabetes and Obesity, Clinical 
Research Institute, HUCH Ltd. The instructors of this thesis are Docent Niina Matikainen, 
M.D., Ph.D., specialist in endocrinology and internal medicine and Reetta Sihvonen, Lector. 
Keywords Apo B48, lipoproteins, SDS-PAGE, ELISA 
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1 Introduction 
 
Cholesterol and triglycerides (TG) received from dietary fats are insoluble in plasma and 
therefore these compounds must be packed to lipoproteins when transported by the 
bloodstream. There are five major classes of lipoproteins: Chylomicrons, VLDL (very-
low-density lipoprotein), IDL (intermediate-low-density lipoproteins), LDL (low-density lip-
oproteins) and HDL (high-density lipoproteins). These lipoprotein particles have different 
densities and they can be separated from fresh-drawn plasma by density gradient ultra-
centrifugation (UCF) with the help of Svedberg flotation rate (Sf), a unit for sedimentation 
rate. (Baynes J., Dominiczak M.H. p.215, 2014.) 
 
Every lipoprotein class (Chylomicron, VLDL, IDL, LDL, HDL) has a typical set of apolipo-
proteins. Apolipoproteins are a group of proteins that compound to lipoprotein particles 
serving as cofactors for enzymes or as ligands for cellular binding. Apolipoproteins also 
take part in the exchange of lipid components between lipoprotein particles. Most signif-
icant apolipoproteins are apoA, apoB, apoC, apoE and apo(a). (Baynes J., Dominiczak 
M.H. p.215, 2014.) 
 
Apolipoprotein B exists in two forms, apolipoprotein B 48 (apoB48) and apolipoprotein B 
100 (apoB100). ApoB48 is synthetized in enterocytes and secreted by the intestine 
whereas apoB100 is synthesized in the liver. ApoB48 binds with chylomicrons whereas 
apoB100 binds with VLDL, IDL and LDL particles. The same gene codes both of these 
apolipoproteins. (Baynes J., Dominiczak M.H. p.216, 2014.) 
 
After a meal, the intestine secretes chylomicron particles, each containing one copy of 
apoB48 protein. ApoB48 serves as a good biological marker for the number of chylomi-
crons and chylomicron remnant particles found in plasma. (Baynes J., Dominiczak M.H. 
2014.) (Adiels M. et al. 2012.) ApoB48 is the only known specific marker of the intestinally 
formed chylomicron particles that largely share the ultracentrifugation properties with he-
patic apoB100 containing VLDL particles (Nakajima K et al. 2014).  
 
ApoB48 containing chylomicrons and apoB100 containing VLDLs are highly triglyceride-
rich particles. Traditionally TG levels have been measured in fasting condition and guide-
lines have defined normal TG level to be < 1.7 mmol/l = 150 mg/dl (Third Report of the 
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National Cholesterol Education Program (NCEP). 2002). On the other hand, epidemio-
logical studies have shown that elevated postprandial (non-fasting) TG concentrations 
are a significant risk indicator for cardiovascular diseases (CVD). (Borén J., Matikainen 
N., Adiels M., Taskinen M-R. 2014.) Measurement of plasma TG does not fully capture 
the atherogenic potential of so called chylomicron remnants and VLDL remnants that are 
able to penetrate the vascular endothelium and to form an atherosclerotic plaque (Borén 
J., Matikainen N., Adiels M., Taskinen M-R. 2014).  
 
Future studies about the impact of high postprandial chylomicron and VLDL levels to 
CVD risk are needed. However, time consuming and costly laboratory methods have 
been an obstacle for larger studies. Separation of plasma samples to lipoprotein fractions 
by ultracentrifugation and the determination of apoB48 and apoB100 by the SDS-PAGE 
(Sodium dodecyl sulphate polyacrylamide gel electrophoresis) method has taken all to-
gether approximately 5 laboratory working days per one patient with fasting and post-
prandial samples. 
 
Measuring apoB48 directly from plasma samples by the ELISA (Enzyme Linked Immuno 
Sorbent Assay) method is much simpler and faster to perform. It takes only one day for 
the results to be ready and one measurement kit can include samples from 16 different 
fat load tests (Kinoshita M. et al. 2005). In this study, we compare these two methods in 
the determination of apoB48: SDS-PAGE and ELISA. 
 
Within this thesis the term “SDS-PAGE” is used in the meaning that the SDS-PAGE 
method contains both, the lipoprotein separation by ultracentrifugation (UCF) and the 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). 
 
2 Background 
 
For decades, apoB48 has been measured by the SDS-PAGE method from lipoprotein 
fractions separated from plasma samples by ultracentrifugation with the help of NaCl 
density gradient (Karpe F., Hamsten A. 1994). A much less time-consuming method, the 
ELISA (enzyme-linked immunosorbent assay) method for measuring apoB48 protein di-
rectly from plasma became available about ten years ago. (Kinoshita M. et al. 2005). In 
our study group, we have used this ELISA method simultaneously with our traditional 
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SDS-PAGE method since the year 2010. Some comparisons of these two methods have 
been made but a thorough comparison with adequate sample number and concentration 
range of the methods still needs to be performed (Borén J., Matikainen N., Adiels M., 
Taskinen M-R. 2014). 
 
The later adapted ELISA method is much faster and simpler to use compared to the 
SDS-PAGE method. ELISA is a very widely used laboratory method and many laborato-
ries already have the facilities to perform it. Ultracentrifuges necessary for the lipoprotein 
fraction separation are a big investment for a research group. Because there is no need 
to separate lipoproteins to lipoprotein fractions before ELISA measurement, the analysis 
of apoB48 can be at the reach of far more laboratories than it used to be using SDS-
PAGE method. From the economical point-of-view, ELISA is a better choice compared 
to SDS-PAGE also because it is so much less time consuming, and gives the possibility 
to get the results in timely manner after the last patient has finished in a clinical study.  
 
Up to now our study group has carried out a comparison of apoB48 results for 10 sub-
jects measured at time points (0, 2, 3, 4, 6, 8 h) after a standardized fat-rich test meal. 
Meaning that a total of 60 apoB48 results were compared. This small-scale comparison 
showed that the plasma values measured by ELISA correlated well with apoB48 results 
measured from the triglyceride-rich lipoprotein particles by the SDS-PAGE method. 
(Borén J., Matikainen N., Adiels M., Taskinen M-R. 2014.) In the present study we per-
formed a large-scale comparison of the methods after we had collected more samples 
and data in our clinical studies. 
 
3 Research questions 
 
The aim of this thesis is to study the comparability of two methods, SDS-PAGE and 
ELISA, for analysing the apoB48 protein from fasting and postprandial blood samples. 
 
The two research questions in this thesis are: 1) Is plasma apoB48 ELISA determination 
comparable with apoB48 determined from triglyceride-rich lipoprotein fractions by SDS-
PAGE? and 2) Does the apoB48 protein concentration range have an influence on the 
correlation coefficient between the methods? 
4 
 
4 Analytical methods 
 
All the study samples have been collected and the laboratory analyses performed during 
years 2012 to 2016. Samples were coded with patient numbers so that no subject par-
ticipating in the studies can be identified. The author has personally analysed most of 
the SDS-PAGE samples and has performed all the data collection for this study. She has 
also taken part in analysing the apoB48 by the ELISA method and in clinical work with 
the study subjects during the fat load tests. 
 
Laboratory work and clinical studies were performed at Biomedicum Helsinki, Research 
Program’s Unit, Marja-Riitta Taskinen’s study group, Diabetes and Obesity, Clinical Re-
search Institute, HUCH Ltd. GCP (good clinical practice) and GLP (good laboratory prac-
tice) were followed closely in all the work. 
 
4.1 Study participants 
 
In this work, we compare apoB48 results measured in two studies called the Fructose-
study and the Gere-study. Before taking part in our clinical studies, all participants were 
informed about the study procedures and asked to give a written informed consent. The 
clinical studies, from which all the data is collected, were ethically approved by the Ethics 
Committee of Helsinki University Hospital. All study procedures were conducted follow-
ing the ethics rules stated by the Declaration of Helsinki.  
 
In the Fructose-study, we recruited 51 non-smoking, obese men (mean body mass index, 
BMI 30.6 kg/m2) to visit our clinic for a fat tolerance test before and after consuming 75 
g of a fructose-sweetened beverage daily for three months. (Matikainen N. et al. 2017). 
The GERE-study consisted of 58 participants, men and women, from families identified 
with hereditary lipid dysfunction and 87 healthy control subjects. 109 of these GERE-
study patients went through a fat tolerance test once. During the performed fat tolerance 
tests, we took apoB48 samples at time points 0h, 3h, 4h, 6h and 8h. Samples for both 
methods (gradient ultracentrifugation + SDS-PAGE and ELISA) were taken at the same 
time points during the test days. 
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Table 1. The number of participants in both studies, the number of fat load tests performed and 
the number of fat load tests with complete apoB48 data available for the method comparison. 
 
 
Number of 
participants 
Number of 
fat load tests 
performed 
Number of 
 fat load tests with 
 complete apoB48 data 
FUCTOSE-study 51 100 100 
GERE-study 145 109 99 
FRUCTOSE and 
GERE 
196 209 199 
 
Two participants in the Fructose-study withdrew their consent before the end of the 
study, and they did not come back to the clinic for the second fat load test. In the Gere-
study, we had to exclude ten patients’ fat load test results from the data analysis because 
there had been difficulties in blood sampling leading to missing apoB48 results for some 
time points. All together, we had 199 fat load tests with complete data (including all time 
points 0h, 3h, 4h, 6h and 8h) for the apoB48 method comparison as shown in Table 1. 
In the present study, the total number of apoB48 measurements for the method compar-
ison was 995. 
 
4.2 The Fat Tolerance Test 
 
On the morning of the fat tolerance test, study subjects came to the clinic after 12 h of 
fasting. Blood samples were taken before the fat containing test meal at 0 h and at 3 h, 
4 h, 6 h and 8 hours after the meal. The test meal contained bread, butter, cheese, sliced 
sausage, boiled egg, paprika, soured milk, orange juice and coffee or tea all together 72 
grams of fat. (Fig. 1) Detailed composition of the test meal is described in Appendix 1. 
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Figure 1. Fat tolerance test meal contains 72 g of fat, 50g of carbohydrates and 38 g of proteins. 
All together 1000 kcal per serving. 
 
Besides the fat load test meal, study subjects were permitted to drink only water during 
the test day. (Mero-Matikainen N. 1999). 
 
4.3 Lipoprotein separation by ultracentrifugation 
 
The lipoproteins were divided to subclasses as follows; Sf > 400 Chylomicrons, Sf > 60 
– 400 VLDL1, Sf 20 – 60 VLDL2, Sf 12 – 20 IDL and Sf 0 – 12 LDL. Sf stands for Sved-
berg’s flotation rate, a unit for sedimentation rate. During the fat load test, 10 ml of EDTA-
plasma was collected at each time point (0h, 3h, 4h, 6h and 8h). Samples were kept on 
ice before centrifugation at +4°C with 2000 G for 10 min. To adjust the plasma density 
to 1.10 g/ml, 4.5 ml of centrifuged plasma was pipetted on top of 0.6315 g NaCl. Then 
4.5 µl of PMSF (phenylmethylsulfonylfluoride 10 mmol/l in isopropanol) and 22.5 µl of 
aprotinin (Trasylol 1400 µg/l) was added to avoid apoB proteolytic degradation. After this, 
the plasma tube was mixed well and left at +4°C overnight. This lipoprotein fraction iso-
lation must be performed from unfrozen EDTA-plasma samples. 
 
The next day the plasma tubes were centrifuged lightly for 2 min at 1000 G and 4 ml of 
plasma with a density of 1.10 g/ml was pipetted at the bottom of Ultra-Clear Beckman 
SW40 ultracentrifuge tubes. Salt solutions of different densities were carefully overlaid 
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with a pump on top of the plasma as follows: first layer 3 ml of 1.065 g/ml, second layer 
3 ml of 1.020 g/ml and third layer 2.8 ml of 1.006 g/ml NaCl solution.  
 
Ultracentrifugation (UCF) was performed with a Beckman L8-55 ultracentrifuge using a 
SW 40 Ti swinging bucket rotor with a speed of 40,000 rpm at +15°C temperature. Lipo-
protein fractions were collected at three different time points: 32 min (Sf > 400, Chylomi-
crons), 3 h 28 min (Sf > 60 – 400, VLDL1) and 17 h (Sf 20 – 60, VLDL2, Sf 12 – 20 IDL 
and Sf 0 – 12 LDL). At these time points, 1 ml of the lipoprotein fraction was collected 
carefully from the top of each tube using a long-form glass pipette (Pasteur). Always 
before the next ultracentrifugation, 1 ml of NaCl solution with a density of 1.006 g/ml was 
added on top of the UCF tube to replace the collected lipoprotein fraction. 
 
4.4 SDS-PAGE 
 
By the SDS-PAGE method, it is possible to measure simultaneously both apoB48 and 
apoB100 protein concentrations. These two forms of apolipoprotein B have different mo-
lecular weights (apoB48 260 kDa and apoB100 550 kDa) and they get separated at the 
same gel electrophoresis run by their different molecular weight. Before the SDS-PAGE 
method is used, all the collected EDTA-plasma samples must be separated to lipoprotein 
fractions by density gradient ultracentrifugation (UCF) as described in chapter 3.3. In this 
study, the SDS-PAGE method for measuring apoB48 was performed according to the 
method of Karpe F. and Hamsten A. (1994). 
 
4.4.1 Sample preparation  
 
After the lipoprotein fraction isolation, the fractions were delipidated in a test tube to ice-
cold methanol-diethyl ether solvent. Then the test tubes were spun three times for 30 
min at 4000 rpm in a centrifuge set to + 4°C, aspirating and adding ice cold diethyl ether 
in between the centrifugations. At the end, the delipidated and dried protein material in 
the bottom of the glass tubes was dissolved into DTT (Dithiotreitol) containing phosphate 
buffer, and samples were stored at - 80°C for the time preceding the SDS-PAGE elec-
trophoresis. Before pipetting the samples for gel electrophoresis, all samples were kept 
for 10 minutes at +80°C and then centrifuged 2 minutes at 1500 G.  
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In this study only chylomicron, VLDL 1 and VLDL 2 fractions were delipidated for the 
apoB48 measurement. This means that all possible apoB48 protein in IDL and LDL frac-
tions was not measured by the SDS-PAGE method. 
 
4.4.2 Gel casting and electrophoresis 
 
All the polyacrylamide gels were casted manually in our laboratory because no commer-
cially sold gels are available. To separate apoB48 and apoB100 in a polyacrylamide gel, 
we prepared a gel consisting linear gradient from 3% of acrylamide to 20% of acrylamide.  
The protein particles were separated based on their molecular weight, apoB48 being 260 
kDa and apoB100 being 550 kDa (Jackson and Williams. 2004). Figure 2. Electrophore-
sis was run by using a vertical Hoefer Mighty Small II electrophoresis apparatus con-
nected to a power supply.  
 
 
 
Figure 2. This picture shows a typical apoB48 SDS-PAGE gel after Coomassie blue staining. 
Exact amounts of isolated protein samples have been pipetted to 14 lanes. First 7 lanes from the 
left contain apoB100 standards pipetted as follows 0.120, 0.120, 0.240, 0.480, 0.720, 0.960 and 
1.2 mg/l. The 8th lane is with locally prepared qualitative control for apoB100 and apoB48. The 
lanes 9 to 14 contain isolated chylomicron fractions pipetted from time points 0, 3, 4, 6 and 8 
hours. Larger apoB100 particles form a protein band closer to the top of the gel and smaller 
apoB48 particles form the protein band closer to the bottom of the gel. 
 
Every gel run included one 6-point standard curve, and every gel had an in-house con-
trol. Gels were run for 2h 20min and fixed for 1 h before 2 h staining with Coomassie 
blue G-250 protein stain in a solution of methanol-acetic acid. Finally, gels were des-
tained three times with the methanol-acetic acid solution. 
 
 
 
ApoB100 
ApoB48 
 1       2       3      4        5        6       7       8       9       10     11     12     13      14 
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4.4.3 Gel imaging and analysing 
 
After the staining process, gels were scanned and analysed by using Amersham Phar-
macia’s Image Quant TL program. The apoB48 and apoB100 protein concentrations 
were obtained from a standard curve included in every gel run. Coomassie blue G-250 
protein dye used for staining the gels stains apoB48 and apoB100 protein particles 
equally and therefore it is possible to use apoB100 standard curve also to measure the 
apoB48 concentrations (Karpe F., Hamsten A. 1994). 
 
To get the final concentrations of apoB48 in mg/l, the results had to be multiplied by 
different dilution factors originating from UCF, delipidating, sample buffer volume added 
on top of the dry protein material and sample volume pipetted on the gel for electropho-
resis. All these calculations demanding great precision were performed using Excel. The 
inter-assay CV % for apoB48 results using this method varied between 14 – 16%.  
 
4.5 ApoB48 ELISA  
 
ApoB48 has a high structural homology with the hepatic apoB100. Therefore, an assay 
using specific anti-apoB48 was not easy to develop. (Kinoshita M. et al. 2005). A reliable 
ELISA (Enzyme Linked Immuno Sorbent Assay) method was finally brought for commer-
cial use by the Japanese company Shibayagi. The antibody used in this sandwich ELISA 
method has a cross-reaction to human apoB100 less than the lower detection limit (2.5 
ng/ml).  
 
Precision and reproducibility of the ELISA method are good, with the average CV being 
between 2.8 to 8.6 %. (Shibayagi. Human Apo B-48 Elisa kit. Web publication.) There 
are also commercial controls available for this ELISA method which is an advantage 
compared to the traditional SDS-PAGE method where only in-house controls can be 
used. The principle of the sandwich enzyme linked immune sorbent assay is described 
in figure 3. 
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Figure 3. This picture explains the principle of sandwich ELISA method. (1) anti-apoB48 antibody 
is pre-coated on the surface of the microplate (2) apoB48 protein attaches to the anti-apoB48 
antibody (3) biotin-conjugated anti-apoB48 attaches to the apoB48 protein particle (4) and (5) 
peroxidase-conjugated streptavidin solution reacts with biotin-conjugated molecules forming a 
blue colour after chromogen substrate reagent addition. Reaction is stopped with acid (1M H2SO4) 
and blue colour turns to yellow. The amount of colour produced is directly comparable with the 
amount of apoB48 protein in the sample. (Picture source: https://de.wikipedia.org/wiki/Enzyme-
linked_Immunosorbent_Assay#/media/File:ELISA-sandwich.svg) 
 
The apoB48 ELISA measurements for this study were performed as described in publi-
cation “Determination of apoB48 in serum by a sandwich ELISA” by Kinoshita M. et al. 
2005. EDTA-plasma samples for ELISA measurements were collected during the fat load 
tests at the same time as the samples for the SDS-PAGE method. After sample collec-
tion, samples were frozen and kept at -80°C before analysing. 
 
Samples were diluted prior to pipetting on the microplate, pre-coated with anti-apoB48. 
Standards and controls were pipetted at the same time with patient samples on the plate. 
Then the microplate was incubated for 1 h at room temperature (RT) to allow the apoB48 
molecules in the pipetted samples to connect with the anti-apoB48 molecules attached 
to the bottom of the wells. 
 
After one hour, all the free-floating material was discarded, and the plate was washed 
four times with ELISA plate washer. After which biotin-conjugated anti-apoB48 was 
added and the plate incubated for one hour and washed again four times. Then peroxi-
dase-conjugated streptavidin solution was added and after 30 min incubation, the plate 
was washed again four times. 
 
At the end, chromogen substrate reagent causing blue colour was added to the wells, 
and after 20 min incubation, the reaction stopper (1M H2SO4) causing yellow colour was 
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added to stop the reaction. The absorbance of each well on the microplate was meas-
ured at 450 nm, and the apoB48 protein concentration results were obtained from a 
standard curve. For the final concentration of apoB48, results were multiplied by the di-
lution factor. 
5 Statistical methods 
 
All study data has been made available to the author in Excel format and statistical anal-
yses were performed using SPSS 22.0 for Windows and Excel 2013. iAUC (incremental 
area under the curve) values were used to evaluate the methods. 
 
5.1 iAUC value 
 
The incremental area under the curve (iAUC) values for both methods were calculated 
using apoB48 concentrations obtained from the 199 fat tolerance tests performed to our 
study subjects. iAUC measured by the Trapezoid method excludes the area left under 
the starting values, i.e. the background, from the total area under the curve (AUC) value. 
The iAUC values were determined by Excel 2013. Figure 4.  
 
 
 
Figure 4. iAUC (incremental area under curve). The unit used for iAUC in this study is mg/l*h. 
 
In this study, the iAUC values represent apoB48 protein concentration changes in blood 
circulation during a fat tolerance test from 0 to 8 hours.  
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5.2 Normality testing 
 
Kolmogorov-Smirnov and Shapiro-Wilk tests in SPSS were used to determine whether 
the data is normally distributed or not. Normality testing was performed because the sta-
tistical method chosen for the statistical analysis depends on the distribution of the data. 
The null hypothesis was that the data is normally distributed and the hypothesis would 
be rejected with a P value less than 0.05. In the analysis it was found that the P value 
was less than 0.05 for three tested parameters and at the lower limit of true significance 
for one test parameter. Table 2. 
 
Table 2. The results of normality testing by Kolmogorov-Smirnov and Shapiro-Wilk tests. P value 
equals to Sig. in this table. 
 
Tests of Normality 
  
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ELISA iAUC 0.046 199   0.200* 0.982 199 0.010 
SDS-page iAUC 0.071 199 0.017 0.931 199 0.001 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
By these Kolmogorov-Smirnov and Shapiro-Wilk normality tests the null hypothesis was 
rejected and the data was found not normally distributed. Because of this finding only 
nonparametric tests were used for the statistical calculations. 
 
5.3 Significance testing 
 
The Wilcoxon signed-rank test was used to test the significance between the results 
obtained by the two different methods (SDS-PAGE and ELISA). This test is a nonpara-
metric test, and it can be used to analyse data which is not normally distributed like the 
data in this study (Satake E. 2015). The null hypothesis was that the difference between 
the results measured by the two methods was obtained by chance, and this hypothesis 
would be rejected with a P value less than 0.05.  
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Figure 5. Wilcoxon signed rank test results. In 190 cases out of 199 the apoB48 concentration 
measured by SDS-page method was found lower than the concentration measured by ELISA. 
 
After analyzing the data by the Wilcoxon signed-rank test, the null hypothesis was re-
jected with a P value of 0.001, meaning that the difference between the results obtained 
by the two different methods was statistically significant, not coincidental. Figure 5.      
  
5.4 Correlation coefficient testing 
 
The Spearman’s rank correlation test was used to determine the correlation coefficient 
between the results obtained by the two different methods. Spearman’s rank correlation 
test was chosen for analysing the data because it is a nonparametric test designed for 
analysing data which is not normally distributed (Satake E. 2015). 
 
The null hypothesis was that there was no correlation between the results obtained by 
the two different methods, and this hypothesis would be rejected with a P value less than 
0.05. After Spearman’s rank correlation testing the null hypothesis was rejected with a P 
value less than 0.001. A statistically significant positive correlation was observed be-
tween the used methods with R value of 0.765. Figure 7. 
 
Spearman’s rank correlation coefficient testing was also performed using five different 
time points: 0, 3, 4, 6 and 8 hours by calculating the correlation individually for each time 
point. In these calculations we used the apoB48 concentrations measured in mg/l instead 
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of iAUC values. The mean concentration of apoB48 protein at each time point (0, 3, 4, 6 
and 8h) was also determined. Table 3. 
 
6 Results 
 
Current data show that the correlation coefficient of measured apoB48 concentrations 
(mg/l) between the methods varied from R = 0.563, P<0.001 to R = 0.844, P<0.001 de-
pending on the concentration of apoB48 in the samples, with weaker correlation coeffi-
cient with samples containing lower apoB48 protein concentration i.e. fasting samples. 
Respectively, the stronger correlations coefficients were observed in the samples with 
higher apoB48 concentrations i.e. 3, 4, 6 and 8 hours after the fat-rich test meal. The 
results of these correlations are shown in Table 3. 
 
Table 3. Correlations (R), P-values and mean values of ELISA and SDS-PAGE methods meas-
ured at five different time points 0, 3, 4, 6 and 8 hours. (fat load test, n = 199) 
 
TIME (hours) R P-value ELISA mean mg/l SDS-PAGE mean mg/l 
0 0.563 0.001 7.4 1.1 
3 0.693 0.001 14.1 3.4 
4 0.763 0.001 15.2 3.6 
6 0.844 0.001 13.5 3.1 
8 0.799 0.001 10.4 2.0 
 
Data also show that plasma apoB48 concentrations measured by ELISA method are 76 
- 85 % higher than the apoB48 concentrations measured by the SDS-PAGE method from 
lipoprotein fractions. This difference in the apoB48 concentration levels between the two 
methods is shown in Figure 6. 
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Figure 6. This figure shows mean apoB48 protein concentrations at time points 0, 3, 4, 6 and 8 
hours measured by both, ELISA (blue line) and SDS-PAGE (red line) methods. Time points 
(hours) are set at the x-axis and apoB48 concentration in (mg/l) at the y-axis. 
 
 
The calculated incremental area under the curve (iAUC) values for apoB48 concentra-
tions during the 199 fat tolerance tests performed showed a strong positive correlation 
between the two methods R = 0.765, P<0.001 as shown in Figure 7. 
 
 
  
 
Figure 7. Correlation R = 0.765, P<0.001 between the iAUC values measured by ELISA and the 
iAUC values measured by SDS-PAGE method. ELISA iAUC values on y-axis and SDS-PAGE 
iAUC values on x-axis. The apoB48 concentration change during the fat load test is expressed 
as mg/l*h. 
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It is normal that in some cases iAUC values are negative. This may occur when the 
apoB48 protein concentration is lower at the end of the fat tolerance test (8 hours) than 
in the beginning of the test (0 hours). 
    
7 Discussion 
 
In the present study, we aimed to assess the comparability of the two methods. We 
asked the question if it is possible to reliably compare data from our previous studies in 
which apoB48 protein was measured by SDS-PAGE to our ongoing studies where 
apoB48 protein is measured by the ELISA method. 
 
Before this study, our group has shown in a small study with data of 60 samples the 
correlation coefficient of AUC values between these two methods to be good ( is R = 
0.88, P<0.001) (Borén J., Matikainen N., Adiels M., Taskinen M-R. 2014). This study 
expands the previous knowledge by showing that the apoB48 concentration measured 
with ELISA directly from plasma reflects well the apoB48 concentration measured from 
the lipoprotein fractions by SDS-PAGE within a wide apoB48 concentration range. 
 
The correlation coefficient of measured apoB48 concentrations between the ELISA and 
SDS-PAGE method varied from R = 0.563, P<0.001 to R = 0.844, P<0.001 depending 
on the concentration of apoB48 in the samples. The iAUC values during the 199 fat tol-
erance test performed showed a strong positive correlation between the two methods (R 
= 0.765, P<0.001) We had data of 995 samples measured by both methods. Our data 
had a wide concentration range of apoB48, including a lot of samples with low, medium 
and high concentrations of apoB48 protein, and we were able to look at correlation co-
efficient values at different protein concentration levels on a larger scale.  
  
It would be ideal if we could find a factor to convert the SDS-PAGE results to be equiva-
lent with measurements performed by the ELISA method. What makes this specific factor 
determination very complicated is the fact that the apoB48 concentrations measured by 
the SDS-PAGE method are 76 - 85 % lower than those measured by the ELISA method, 
and correlation coefficient values depend on the concentration of the apoB48 protein in 
the samples. The correlation coefficient decreases simultaneously with the decreasing 
concentration of the apoB48 protein.  
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Several factors may explain the observed difference between the apoB48 protein con-
centration levels measured with SDS-PAGE or ELISA methods. This observation may 
partly be explained by the difference in the sensitivity of the compared methods and also 
by the difference in the sample material used for the methods. In this study only chylo-
micron and VLDL fractions were delipidated for the apoB48 measurements performed 
by SDS-PAGE method. The apoB48 concentrations used for measuring iAUC values for 
SDS-PAGE method were obtained by adding together the apoB48 results measured 
from the different lipoprotein fractions (Chylomicrons and VLDLs). This means that all 
apoB48 protein potentially in IDL and LDL fractions was not measured by the SDS-PAGE 
method. Furthermore, we also must take into consideration that during the collection of 
these lipoprotein fractions used for the SDS-PAGE method and during the sample prep-
aration some material is always lost no matter how carefully the instructions are followed. 
 
By using the ELISA method directly on plasma samples, there is no fear of losing sample 
material. Therefore, all possible apoB48 protein in the samples is determined and the 
measured concentrations represent complete apoB48 protein concentration in plasma. 
This and methodological factors may explain the higher protein concentrations obtained 
by ELISA method. On the other hand, the obvious weakness of the ELISA method is that 
only total plasma apoB48 concentration is measured, and investigators are left without 
the valuable information about the apoB48 concentration in each individual lipoprotein 
fraction. 
 
In addition to the two methods compared in this study, there have been some experi-
ments to analyse apoB48 protein by immunoblotting. However, these experiments have 
not succeeded because there has been too much intra- and inter-assay variability in the 
results due to antibody interactions and the number of laboratory steps involved. (Jack-
son K. and Williams C. 2004). 
 
For this study the data was collected during four years (2012 – 2016). Especially SDS-
PAGE laboratory analysis was laborious and required the contribution of one laboratory 
technologist over the years. During all these years, when working with the study subjects, 
the principles of GCP were followed carefully. The subjects were always well informed 
both orally and in writing about the study procedures before participating in the clinical 
studies, and they all gave a written informed consent at the first clinic visit. The work in 
the laboratory was performed in accordance with GLP and the personnel taking part to 
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the laboratory work were well qualified. The data of this study were recorded reliably and 
traceably in the laboratory to enable the data management afterwards. All these study 
procedures followed during the years make the data used for this method comparison 
reliable and accurate. 
 
In conclusion, this study confirms our earlier findings made with a smaller amount of 
data. Our study also expands the previous knowledge by showing that the apoB48 con-
centration measured with ELISA directly from plasma reflects well the apoB48 concen-
tration measured from the lipoprotein fractions by SDS-PAGE within a wide apoB48 con-
centration range. In the future, the less time-consuming apoB48 ELISA measurement 
can easily be implemented in clinical laboratories and used as a biological marker of 
intestinal chylomicron and VLDL particle number when evaluating the risk of CVD, espe-
cially in hypertriglyceridemic patients. 
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ABBREVIATIONS 
 
ApoB Apolipoprotein B 
ApoB48 Apolipoprotein B 48 
ApoB100 Apolipoprotein B 100 
AUC Area under curve 
iAUC Area under incremental curve 
BMI Body mass index 
CV Coefficient of variation 
CVD Cardio vascular disease 
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme Linked Immuno Sorbent Assay 
GCP Good clinical practice 
GLP Good laboratory practice 
HDL High-density lipoprotein 
HUCH Helsinki university central hospital 
IDL Intermediate-low-density lipoprotein 
LDL Low-density lipoprotein 
PMSF Phenylmethylsulfonylfluoride 
R Correlation 
Rpm Revolutions per minute 
RT Room temperature 
SDS-PAGE *) Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
Sf Svedberg flotation rate, a unit for sedimentation rate 
TG Triglyceride 
UCF Ultracentrifugation 
VLDL Very-low-density lipoprotein 
 
 
*) Within this thesis the term “SDS-PAGE” is used in the meaning that the SDS-PAGE 
method contains both, the lipoprotein separation by ultracentrifugation (UCF) and the 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). 
 
. 
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Fat load test meal contents 
 
Bread  65 g 
Butter  35 g 
Cheese  50 g 
Sliced sausage 40 g 
Boiled eggs  70 g 
Fresh paprika 50 g 
Soured whole milk 1 % 200 g 
Orange juice  1.25 dl 
Coffee 
 
 
The fatty acids of the meal 
65% SFA 
30 % MUFA 
5 % PUFA 
 
 
Fat  65%     → 72 g 
Carbohydrate 20%     →     50 g 
Protein  15%     →  38 g    
 
Cholesterol  490 mg 
Energy  1000 kcal 
 
 
 
